Integer (NYSE:ITGR) Announces Quarterly Earnings Results

Integer (NYSE:ITGR) released its quarterly earnings data on Thursday. The medical equipment provider reported $1.34 earnings per share for the quarter, missing the consensus estimate of $1.68 by ($0.34), FiscalAI reports. The business had revenue of $449.66 million during the quarter, compared to analysts’ expectations of $456.91 million. Integer had a return on equity of 11.85% and a net margin of 5.68%. The company’s quarterly revenue was down 3.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.79 EPS.

Integer Price Performance

ITGR opened at $126.59 on Friday. The stock has a fifty day simple moving average of $126.23 and a two-hundred day simple moving average of $100.82. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The company has a market cap of $4.30 billion, a price-to-earnings ratio of 21.44, a price-to-earnings-growth ratio of 2.41 and a beta of 0.58. Integer has a 12-month low of $62.10 and a 12-month high of $126.83.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Citigroup upped their target price on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Benchmark downgraded shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Finally, Weiss Ratings raised shares of Integer from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. One investment analyst has rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $113.67.

Insiders Place Their Bets

In related news, insider Andrew Senn sold 9,408 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the transaction, the insider directly owned 5,405 shares in the company, valued at $682,651.50. This trade represents a 63.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kirk K. Thor sold 11,767 shares of Integer stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the transaction, the insider directly owned 7,153 shares of the company’s stock, valued at approximately $902,923.19. This trade represents a 62.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 40,948 shares of company stock worth $5,169,920. Company insiders own 1.10% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.

Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.

Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.